These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6389273)

  • 1. Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.
    Kumar N; Vij JC; Karol A; Anand BS
    Gut; 1984 Nov; 25(11):1199-202. PubMed ID: 6389273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
    Ström M; Gotthard R; Bodemar G; Walan A
    Scand J Gastroenterol; 1981; 16(5):593-602. PubMed ID: 7034155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal ulcer healing with four antacid tablets daily.
    Weberg R; Berstad A; Lange O; Schultz T; Aubert E
    Scand J Gastroenterol; 1985 Nov; 20(9):1041-5. PubMed ID: 3911365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study.
    Lam SK; Lam KC; Lai CL; Yeung CK; Yam LY; Wong WS
    Gastroenterology; 1979 Feb; 76(2):315-22. PubMed ID: 365665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of peroral antacid treatment in patients with acute upper gastrointestinal haemorrhage: a randomized controlled trial.
    Kittang E; Aadland E; Oyen D; Holm HA; Berstad A; Pytte R; Qvigstad T; Tommelstad T
    Scand J Gastroenterol Suppl; 1982; 75():109-12. PubMed ID: 6755651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
    Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
    Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antacid treatment of duodenal ulcer.
    Becker U; Lindorff K; Andersen C; Ranløv PJ
    Acta Med Scand; 1987; 221(1):95-101. PubMed ID: 3551508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal ulcer therapy with low-dose antacids: a multicenter trial.
    Nauert C; Caspary WF
    J Clin Gastroenterol; 1991; 13 Suppl 1():S149-54. PubMed ID: 1940190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial.
    Lauritsen K; Bytzer P; Hansen J; Bekker C; Rask-Madsen J
    Scand J Gastroenterol; 1985 Jan; 20(1):123-8. PubMed ID: 3887547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very-low dose antacid in treatment of duodenal ulcer. Comparison with cimetidine.
    Zaterka S; Cordeiro F; Lyra LG; Toletino MM; Miszputen SJ; Jorge JL; Silva EP; Vieira FE; Modena JL; Massuda HK
    Dig Dis Sci; 1991 Oct; 36(10):1377-83. PubMed ID: 1914758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of duodenal ulcer with an antacid regimen.
    Peterson WL; Sturdevant RA; Frankl HD; Richardson CT; Isenberg JI; Elashoff JD; Sones JQ; Gross RA; McCallum RW; Fordtran JS
    N Engl J Med; 1977 Aug; 297(7):341-5. PubMed ID: 876324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antacids for peptic ulcer: do we have anything better?
    Berstad A; Weberg R
    Scand J Gastroenterol Suppl; 1986; 125():32-41. PubMed ID: 3547614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer.
    Bianchi Porro G; Parente F; Lazzaroni M; Baroni S; Panza E
    J Clin Gastroenterol; 1986 Apr; 8(2):141-5. PubMed ID: 3745847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antacid therapy of duodenal ulcer. Effects of smaller doses.
    Berstad A
    Scand J Gastroenterol Suppl; 1982; 75():97-9. PubMed ID: 6128786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent ulcer after successful treatment with cimetidine or antacid.
    Ippoliti A; Elashoff J; Valenzuela J; Cano R; Frankl H; Samloff M; Koretz R
    Gastroenterology; 1983 Oct; 85(4):875-80. PubMed ID: 6350097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro evaluation of magnesium-aluminum hydroxide antacid tablets and liquid.
    Barnett CC; Richardson CT
    Dig Dis Sci; 1985 Nov; 30(11):1049-52. PubMed ID: 4053915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tablet and liquid antacid in the treatment of duodenal ulcer.
    Kumar N; Vij JC; Anand BS
    Indian J Gastroenterol; 1986 Apr; 5(2):101-2. PubMed ID: 3699854
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of cimetidine and Mylanta II in the 6-week treatment of gastric ulcer.
    Sherbaniuk RW; Wensel RH; Bailey RJ; Kirdeikis P; Fisher D; Thomson AB
    J Clin Gastroenterol; 1985 Jun; 7(3):211-5. PubMed ID: 3894494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antacid maintenance therapy in the prevention of duodenal ulcer relapse.
    Bardhan KD; Hunter JO; Miller JP; Thomson AB; Graham DY; Russell RI; Sontag S; Hines C; Martin T; Gaussen L
    Gut; 1988 Dec; 29(12):1748-54. PubMed ID: 3065157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for healing of duodenal ulcer under antacid treatment: do ulcer patients need individual treatment?
    Massarrat S; Müller HG; Schmitz-Moormann P
    Gut; 1988 Mar; 29(3):291-7. PubMed ID: 3356359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.